Stock Analysts' Downgrades for August 1st (APLS, BRO, CLAR, CNI, DMPZF, EL, EMN, FLO, FTI, HLF)

Stock Analysts’ downgrades for Tuesday, August 1st: Apellis Pharmaceuticals (NASDAQ:APLS) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. Bank of America Co. currently has $40.00 price target on the stock, down from their previous price target of $114.00. Brown & Brown (NYSE:BRO) was downgraded by analysts […]

Related Keywords

United States ,Canada ,America ,Canadian ,Piper Sandler ,Stifel Nicolaus ,Robertw Baird ,William Blair ,Raymond James ,Citigroup Inc ,Wells Fargo Company ,Reata Pharmaceuticals ,Topaz Energy ,Telia Company ,Berenberg Bank ,Deutsche Bank Aktiengesellschaft ,Hovde Group ,Valley National Bancorp ,Domino Pizza Group ,News Ratings For Apellis Pharmaceuticals Inc Daily ,Apellis Pharmaceuticals ,Cantor Fitzgerald ,Credit Suisse Group ,National Bank Financial ,Barclays Plc ,Lauder Companies ,Canadian National Railway ,America Co ,Insteel Industries ,Apellis Pharmaceuticals Inc ,Stock Analyst ,National Railway ,Pizza Group ,Peel Hunt ,Kepler Capital Markets ,Wells Fargo ,Loop Capital ,Suisse Group ,Crest Metals ,National Bancorp ,Info Technologies ,Apellis Pharmaceuticals Inc Daily ,Brown Inc ,Clarus Co ,Dominos Pizza Group Plc ,The Estée Lauder Companies Inc ,Eastman Chemical ,Flowers Foods Inc ,Technipfmc Plc ,Herbalife Ltd ,